Artículos de revistas sobre el tema "Toll-like receptors"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Toll-like receptors.

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Toll-like receptors".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Lien, Egil y Robin R. Ingalls. "Toll-like receptors". Critical Care Medicine 30, Suppl. (enero de 2002): S1—S11. http://dx.doi.org/10.1097/00003246-200201001-00001.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Erickson, Benjamin, Kirk Sperber y William H. Frishman. "Toll-Like Receptors". Cardiology in Review 16, n.º 6 (noviembre de 2008): 273–79. http://dx.doi.org/10.1097/crd.0b013e3181709fd8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Warren, H. Shaw. "Toll-like receptors". Critical Care Medicine 33, Suppl (diciembre de 2005): S457—S459. http://dx.doi.org/10.1097/01.ccm.0000185504.39347.5d.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Shin, Ho. "Toll-like Receptors". British Journal of Medicine and Medical Research 3, n.º 1 (10 de enero de 2013): 58–68. http://dx.doi.org/10.9734/bjmmr/2013/2071.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Muzio, Marta y Alberto Mantovani. "Toll-like receptors". Microbes and Infection 2, n.º 3 (marzo de 2000): 251–55. http://dx.doi.org/10.1016/s1286-4579(00)00303-8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Moresco, Eva Marie Y., Diantha LaVine y Bruce Beutler. "Toll-like receptors". Current Biology 21, n.º 13 (julio de 2011): R488—R493. http://dx.doi.org/10.1016/j.cub.2011.05.039.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Bilak, H., S. Tauszig-Delamasure y J. L. Imler. "Toll and Toll-like receptors in Drosophila". Biochemical Society Transactions 31, n.º 3 (1 de junio de 2003): 648–51. http://dx.doi.org/10.1042/bst0310648.

Texto completo
Resumen
The Drosophila Toll receptor controls the immune response to Gram-positive bacteria and fungi by activating a signalling pathway partially conserved throughout evolution. The Drosophila genome encodes eight additional Toll-related receptors, most of which appear to carry out developmental rather than immune functions. One exception may be Toll-9, which shares structural and functional similarities with mammalian TLRs.
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Akira, Shizuo. "Mammalian Toll-like receptors". Current Opinion in Immunology 15, n.º 1 (febrero de 2003): 5–11. http://dx.doi.org/10.1016/s0952-7915(02)00013-4.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Akira, Shizuo. "Mammalian Toll-like receptors". Current Opinion in Immunology 15, n.º 2 (abril de 2003): 238. http://dx.doi.org/10.1016/s0952-7915(03)00005-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Modlin, Robert L. "Mammalian Toll-like receptors". Annals of Allergy, Asthma & Immunology 88, n.º 6 (junio de 2002): 543–48. http://dx.doi.org/10.1016/s1081-1206(10)61883-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Blasius, Amanda L. y Bruce Beutler. "Intracellular Toll-like Receptors". Immunity 32, n.º 3 (marzo de 2010): 305–15. http://dx.doi.org/10.1016/j.immuni.2010.03.012.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Brownlie, Robert y Brenda Allan. "Avian toll-like receptors". Cell and Tissue Research 343, n.º 1 (1 de septiembre de 2010): 121–30. http://dx.doi.org/10.1007/s00441-010-1026-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Kaisho, Tsuneyasu y Shizuo Akira. "Toll-like receptors as adjuvant receptors". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1589, n.º 1 (febrero de 2002): 1–13. http://dx.doi.org/10.1016/s0167-4889(01)00182-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Seya, Tsukasa, Masashi Shingai y Misako Matsumoto. "Toll-like receptors that sense viral infection". Uirusu 54, n.º 1 (2004): 1–8. http://dx.doi.org/10.2222/jsv.54.1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Lipinski, Jay H., Nicole R. Falkowski, Gary B. Huffnagle, John R. Erb-Downward, Robert P. Dickson, Beth B. Moore y David N. O’Dwyer. "Toll-like receptors, environmental caging, and lung dysbiosis". American Journal of Physiology-Lung Cellular and Molecular Physiology 321, n.º 2 (1 de agosto de 2021): L404—L415. http://dx.doi.org/10.1152/ajplung.00002.2021.

Texto completo
Resumen
Recent studies have implicated lung microbiota in shaping local alveolar immune responses. Toll-like receptors are major sensors of microbiota and determinants of local epithelial homeostasis. The impact of toll-like receptor deficiency on lung microbiota is unknown. To determine whether the absence of toll-like receptors results in altered lung microbiota or dysbiosis, we compared lung microbiota in wild-type and toll-like receptor-deficient experimental mice using 16S ribosomal RNA gene quantification and sequencing. We used a randomized environmental caging strategy to determine the impact of toll-like receptors on lung microbiota. Lung microbiota are detectable in toll-like receptor-deficient experimental mice and exhibit considerable variability. The lung microbiota of toll-like receptor-deficient mice are altered in community composition (PERMANOVA P < 0.001), display reduced diversity ( t test P = 0.0075), and bacterial burden ( t test P = 0.016) compared with wild-type mice with intact toll-like receptors and associated signaling pathways. The lung microbiota of wild-type mice when randomized to cages with toll-like receptor-deficient mice converged with no significant difference in community composition (PERMANOVA P > 0.05) after 3 wk of cohousing. The lung microbiome of toll-like receptor-deficient mice is distinct from wild-type mice and may be less susceptible to the effects of caging as an environmental variable. Our observations support a role for toll-like receptor signaling in the shaping of lung microbiota.
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Mallard, Carina. "Innate Immune Regulation by Toll-Like Receptors in the Brain". ISRN Neurology 2012 (14 de octubre de 2012): 1–19. http://dx.doi.org/10.5402/2012/701950.

Texto completo
Resumen
The innate immune system plays an important role in cerebral health and disease. In recent years the role of innate immune regulation by toll-like receptors in the brain has been highlighted. In this paper the expression of toll-like receptors and endogenous toll-like receptor ligands in the brain and their role in cerebral ischemia will be discussed. Further, the ability of systemic toll-like receptor ligands to induce cerebral inflammation will be reviewed. Finally, the capacity of toll-like receptors to both increase (sensitization) and decrease (preconditioning/tolerance) the vulnerability of the brain to damage will be disclosed. Studies investigating the role of toll-like receptors in the developing brain will be emphasized.
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

MIYAKE, Kensuke. "Toll-like Receptors and Their Roles in Defense Responses Against Infection". Journal of the Japanese Association for Infectious Diseases 77, n.º 7 (2003): 473–79. http://dx.doi.org/10.11150/kansenshogakuzasshi1970.77.473.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Falck-Hansen, Mika, Christina Kassiteridi y Claudia Monaco. "Toll-Like Receptors in Atherosclerosis". International Journal of Molecular Sciences 14, n.º 7 (4 de julio de 2013): 14008–23. http://dx.doi.org/10.3390/ijms140714008.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

O'mahony, C. y N. Steedman. "Toll-like receptors: that's weird!" International Journal of STD & AIDS 21, n.º 6 (junio de 2010): 450. http://dx.doi.org/10.1258/ijsa.2010.010184.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Tobias, P. S. y L. K. Curtiss. "Toll-like receptors in atherosclerosis". Biochemical Society Transactions 35, n.º 6 (23 de noviembre de 2007): 1453–55. http://dx.doi.org/10.1042/bst0351453.

Texto completo
Resumen
At one time, atherosclerosis was thought to be a simple lipid storage disease. However, it is now recognized as a chronic and progressive inflammation of the arterial wall. Gene deletion experiments in murine models of atherosclerosis that reduce the inflammatory process also reduce disease severity. Identifying the initiators and mediators of that inflammation can provide promising avenues for prevention or therapy. Two prominent risk factors, hyperlipidaemia and infectious disease, point to innate immune mechanisms as potential contributors to proatherogenic inflammation. The TLRs (Toll-like receptors), pro-inflammatory sensors of pathogens, are potential links between inflammation, infectious disease and atherosclerosis. A mechanism for hyperlipidaemic initiation of sterile inflammation can be postulated because oxidized lipoproteins or their component oxidized lipids have been identified as TLR ligands. Moreover, infectious agents are correlated with atherosclerosis risk. We have identified a role for TLR2 in atherosclerosis in mice deficient in low-density lipoprotein receptor. We observed that proatherogenic TLR2 responses to unknown endogenous or unknown endemic exogenous agonists are mediated by non-BMDC (bone-marrow-derived cells), which can include endothelial cells. In contrast, the proatherogenic TLR2 responses to the defined synthetic exogenous agonist Pam3 CSK4 are mediated at least in part by BMDC, which can include lymphocytes, monocytes/macrophages and dendritic cells. TLR2-mediated cell activation in response to endogenous and exogenous agents is proatherogenic in hyperlipidaemic mice.
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Koga, Kaori y Gil Mor. "Toll-like Receptors and Pregnancy". Reproductive Sciences 14, n.º 4 (mayo de 2007): 297–99. http://dx.doi.org/10.1177/1933719107304562.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Espevik, T. "TRAFFICKING OF TOLL-LIKE RECEPTORS". Shock 21, Supplement (marzo de 2004): 10. http://dx.doi.org/10.1097/00024382-200403001-00038.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Fischer, Maria y Marc Ehlers. "Toll-like Receptors in Autoimmunity". Annals of the New York Academy of Sciences 1143, n.º 1 (noviembre de 2008): 21–34. http://dx.doi.org/10.1196/annals.1443.012.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Wong, F. Susan y Li Wen. "Toll-Like Receptors and Diabetes". Annals of the New York Academy of Sciences 1150, n.º 1 (diciembre de 2008): 123–32. http://dx.doi.org/10.1196/annals.1447.063.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Ermertcan, A. T., F. Öztürk y K. Gündüz. "Toll-like receptors and skin". Journal of the European Academy of Dermatology and Venereology 25, n.º 9 (24 de marzo de 2011): 997–1006. http://dx.doi.org/10.1111/j.1468-3083.2011.04049.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Delgado, Mónica A., Rasha A. Elmaoued, Alexander S. Davis, George Kyei y Vojo Deretic. "Toll-like receptors control autophagy". EMBO Journal 27, n.º 7 (13 de marzo de 2008): 1110–21. http://dx.doi.org/10.1038/emboj.2008.31.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Tuon, Felipe F., Valdir S. Amato, Hélio A. Bacha, Tariq AlMusawi, Maria I. Duarte y Vicente Amato Neto. "Toll-Like Receptors and Leishmaniasis". Infection and Immunity 76, n.º 3 (10 de diciembre de 2007): 866–72. http://dx.doi.org/10.1128/iai.01090-07.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Miller, Lloyd S. "Toll-Like Receptors in Skin". Advances in Dermatology 24 (noviembre de 2008): 71–87. http://dx.doi.org/10.1016/j.yadr.2008.09.004.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

Rassa, John C. y Susan R. Ross. "Viruses and Toll-like receptors". Microbes and Infection 5, n.º 11 (septiembre de 2003): 961–68. http://dx.doi.org/10.1016/s1286-4579(03)00193-x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Finberg, Robert W. y Evelyn A. Kurt-Jones. "Viruses and Toll-like receptors". Microbes and Infection 6, n.º 15 (diciembre de 2004): 1356–60. http://dx.doi.org/10.1016/j.micinf.2004.08.013.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Michie, Colin A. "Triage by Toll-like receptors". Trends in Molecular Medicine 8, n.º 1 (enero de 2002): 6. http://dx.doi.org/10.1016/s1471-4914(01)02231-6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Okun, Eitan, Kathleen J. Griffioen, Justin D. Lathia, Sung-Chun Tang, Mark P. Mattson y Thiruma V. Arumugam. "Toll-like receptors in neurodegeneration". Brain Research Reviews 59, n.º 2 (marzo de 2009): 278–92. http://dx.doi.org/10.1016/j.brainresrev.2008.09.001.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Iribarren, Pablo y Ji Ming Wang. "Toll-like receptors and diseases". International Immunopharmacology 11, n.º 10 (octubre de 2011): 1389–90. http://dx.doi.org/10.1016/j.intimp.2011.08.010.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Ishii, Ken J. y Shizuo Akira. "Toll-like receptors and sepsis". Current Infectious Disease Reports 6, n.º 5 (septiembre de 2004): 361–66. http://dx.doi.org/10.1007/s11908-004-0034-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

Kim, G. K. y J. Q. Del Rosso. "Toll-like receptors and skin". Yearbook of Dermatology and Dermatologic Surgery 2012 (enero de 2012): 334–35. http://dx.doi.org/10.1016/j.yder.2012.02.163.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Rakoff-Nahoum, Seth y Ruslan Medzhitov. "Toll-like receptors and cancer". Nature Reviews Cancer 9, n.º 1 (4 de diciembre de 2008): 57–63. http://dx.doi.org/10.1038/nrc2541.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

Singh, Madhu V. y François M. Abboud. "Toll-like receptors and hypertension". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 307, n.º 5 (1 de septiembre de 2014): R501—R504. http://dx.doi.org/10.1152/ajpregu.00194.2014.

Texto completo
Resumen
Hypertension and associated inflammatory processes that accelerate cardiovascular damage are regulated by the innate immune system. Toll-like receptors (TLR) are major components of the innate immune system that recognize endogenous damage-associated molecular patterns to activate prominent inflammatory signaling including activation of nuclear factor-κB (NF-κB). However, the role of TLR in the etiology of hypertension is not well understood. TLR signaling is dependent on adaptor proteins that, along with the TLR expression patterns, confer specificity of the inflammatory response and its pathological targets. Here we review the conceptual framework of how TLR and their adaptor proteins may differentially affect hypertension and cardiac hypertrophy by different stimuli.
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Petry, Vanessa y Anthony A. Gaspari. "Toll-like receptors and dermatology". International Journal of Dermatology 48, n.º 6 (junio de 2009): 558–70. http://dx.doi.org/10.1111/j.1365-4632.2009.04111.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Hurst, Julia y Philipp von Landenberg. "Toll-like receptors and autoimmunity". Autoimmunity Reviews 7, n.º 3 (enero de 2008): 204–8. http://dx.doi.org/10.1016/j.autrev.2007.11.006.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

O'Neill, L. A. J. "Toll-like receptors in cancer". Oncogene 27, n.º 2 (enero de 2008): 158–60. http://dx.doi.org/10.1038/sj.onc.1210903.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Hansbro, Philip M., Tatt Jhong Haw, Malcolm R. Starkey y Kensuke Miyake. "Toll-like receptors in COPD". European Respiratory Journal 49, n.º 5 (mayo de 2017): 1700739. http://dx.doi.org/10.1183/13993003.00739-2017.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Bell, Jennifer. "Living without Toll-like receptors". Nature Reviews Immunology 3, n.º 4 (abril de 2003): 261. http://dx.doi.org/10.1038/nri1073.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Grote, Karsten, Harald Schütt y Bernhard Schieffer. "Toll-Like Receptors in Angiogenesis". Scientific World JOURNAL 11 (2011): 981–91. http://dx.doi.org/10.1100/tsw.2011.92.

Texto completo
Resumen
Toll-like receptors (TLRs) are known as pattern-recognition receptors related to the Toll protein ofDrosophila. After recognition of pathogen-associated molecular patterns of microbial origin, the TLRs alert the immune system, and initiate innate and adaptive immune responses. The TLR system, though, is not confined solely to the leukocyte-mediated immune defense against exogenous pathogens. Besides myeloid cells, TLR expression has been reported in multiple tissues and cell types, including epithelial and endothelial cells. Moreover, despite the microbial patterns that are commonly accepted as TLR ligands, there is increasing evidence that TLRs also recognize host-derived molecules. In this regard, recent studies point to an involvement of TLRs in various chronic inflammatory disorders and cardiovascular diseases, including atherosclerosis, rheumatoid arthritis, systemic lupus erythematosus, and even cancer. A common feature of these disorders is an enhanced so-called inflammation-induced angiogenesis. However, inflammation-induced angiogenesis is not solely a key component of pathogen defense during acute infection or chronic inflammatory disorders, but also plays a critical role in repair mechanisms, e.g., wound healing and subsequent tissue regeneration. Interestingly, the latest research could coincidentally demonstrate that TLR activation promotes angiogenesis in various inflammatory settings in response to both exogenous and endogenous ligands, although the precise mode of action of TLRs in this context still remains ambiguous. The objective of this review is to present evidence for the implication of TLRs in angiogenesis during physiological and pathophysiological processes, and the potential clinical relevance for new treatment regimes involving TLR modulation.
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Fiset, Pierre Olivier, Meri Katarina Tulic y Qutayba Hamid. "Toll-like receptors and atopy". Journal of Allergy and Clinical Immunology 116, n.º 2 (agosto de 2005): 467–70. http://dx.doi.org/10.1016/j.jaci.2005.04.034.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Finberg, Robert W., Jennifer P. Wang y Evelyn A. Kurt-Jones. "Toll like receptors and viruses". Reviews in Medical Virology 17, n.º 1 (2006): 35–43. http://dx.doi.org/10.1002/rmv.525.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Goodsell, David S. "Recognition highlights: Toll-like receptors". Journal of Molecular Recognition 19, n.º 5 (2006): 387–88. http://dx.doi.org/10.1002/jmr.778.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Bernard, Marina y Rosario Rizzuto. "Toll‐like receptors hit calcium". EMBO reports 15, n.º 5 (abril de 2014): 468–69. http://dx.doi.org/10.1002/embr.201438685.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Mempel, Martin, Behnam Naderi Kalali, Markus Ollert y Johannes Ring. "Toll-Like Receptors in Dermatology". Dermatologic Clinics 25, n.º 4 (octubre de 2007): 531–40. http://dx.doi.org/10.1016/j.det.2007.06.014.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Tang, Xiaoqin, Qian Xu, Shuo Yang, Xinwu Huang, Long Wang, Feihong Huang, Jiesi Luo et al. "Toll-like Receptors and Thrombopoiesis". International Journal of Molecular Sciences 24, n.º 2 (5 de enero de 2023): 1010. http://dx.doi.org/10.3390/ijms24021010.

Texto completo
Resumen
Platelets are the second most abundant blood component after red blood cells and can participate in a variety of physiological and pathological functions. Beyond its traditional role in hemostasis and thrombosis, it also plays an indispensable role in inflammatory diseases. However, thrombocytopenia is a common hematologic problem in the clinic, and it presents a proportional relationship with the fatality of many diseases. Therefore, the prevention and treatment of thrombocytopenia is of great importance. The expression of Toll-like receptors (TLRs) is one of the most relevant characteristics of thrombopoiesis and the platelet inflammatory function. We know that the TLR family is found on the surface or inside almost all cells, where they perform many immune functions. Of those, TLR2 and TLR4 are the main stress-inducing members and play an integral role in inflammatory diseases and platelet production and function. Therefore, the aim of this review is to present and discuss the relationship between platelets, inflammation and the TLR family and extend recent research on the influence of the TLR2 and TLR4 pathways and the regulation of platelet production and function. Reviewing the interaction between TLRs and platelets in inflammation may be a research direction or program for the treatment of thrombocytopenia-related and inflammatory-related diseases.
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Bacharewicz, Joanna, Teresa Reduta y Iwona Flisiak. "The role of Toll-like receptors in skin diseases". Dermatology Review 4 (2014): 309–18. http://dx.doi.org/10.5114/dr.2014.45126.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía